ROSHNI-2 – Using a culturally adapted model of recruitment, engagement and retention to mental health research for British South Asian Women experiencing symptoms of Post Natal Depression

An extension of ROSHNI-D, ROSHNI-2 is a national scale research study, designed to address the rise of British South Asian (BSA) women who experience Post-Natal Depression.

We aim to evaluate the clinical and cost effectiveness of a culturally adapted group psychological intervention (The Positive Health Programme), in primary care for British South Asian women with postnatal depression compared with treatment as usual.

ROSHNI-2 is funded by the National Institute for Health Research, Health Technology Assessment Programme.

The trial started in July 2016 and will be conducted over 4 years. Recruitment of participants began in February 2017

Study areas include the North West, Yorkshire, East Midlands, Glasgow & London.

Qualitative work will be carried out to refine and improve our study processes and experience of working with this study population.

Background

Postnatal depression is an important public health concern. Its prevalence in the UK is 15%, yet British South Asian (BSA) women have a higher prevalence of 17% during the prenatal period and 19% during the post natal period. Despite this, British South Asian mothers access to therapeutic interventions remains limited.

The main barriers include:

Lack of culturally and linguistically appropriate services
Lack of trust/fear of health services
Lack of awareness of mental illnesses
Stigma of mental illnesses

The primary objective of the project is to evaluate the clinical and cost effectiveness of a culturally adapted group psychological intervention (Positive Health Programme, PHP) in primary care for British South Asian (BSA) women with postnatal depression compared with treatment as usual (TAU).

The secondary objective of the study is to evaluate the impact of the intervention on secondary outcomes (health status and quality adjusted life years, parenting competence, social function, anxiety, satisfaction with care) compared to treatment as usual.